Impact Factor Journals

KVASNICA, M., M. URBAN, N. DICKINSON, J. ŠAREK
Pentacyclic triterpenoids with nitrogen- and sulfur-containing heterocycles: synthesis and medicinal significance. Natural Product Reports. 2015, 20(32), 1303-1330, ISSN: 0265-0568, PMID: 26030604,
URBANOVA, R., L. HUMPLIKOVA, H. DŘÍMALOVÁ, V. PROCHAZKA, P. TURCSANYI, Z. PIKALOVA, M. HOLZEROVA, L. KRUZOVA, M. JAROSOVA, J. URBAN, J. VRBKOVÁ, K. INDRAK, T. PAPAJIK
Biological and clinical characteristics of patients with chronic lymphocytic leukemia with the IGHV3-21 and IGHV1-69; analysis of data from a single center. Neoplasma. 2015, 62(4), 618-626, ISSN: 0028-2685, PMID: 25997971,
KOUDELÁKOVÁ, V., J. BERKOVCOVÁ, R. TROJANEC, J. VRBKOVÁ, L. RADOVÁ, J. EHRMANN, Z. KOLÁŘ, B. MELICHAR, M. HAJDÚCH
Evaluation of HER2 Gene Status in Breast Cancer Samples with Indeterminate Fluorescence in Situ Hybridization by Quantitative Real-Time PCR Method. Journal of Molecular Diagnostic. 2015, 17(4), 446-455, ISSN: 1525-1578, PMID: 25956448,  PDF.
BORKOVÁ, L., L. JASILKOVA, J. ŘEHULKA, K. FRISONSOVA, M. URBAN, I. FRYDRYCH, I. POPA, M. HAJDÚCH, N. DICKINSON, M. VLK, P. DŽUBÁK, J. ŠAREK
Synthesis of cytotoxic 2,2-difluoroderivatives of dihydrobetulinic acid and allobetulin and study of their impact on cancer cells. European Journal of Medicinal Chemistry. 2015, 96(-), 482-490, ISSN: 0223-5234, PMID: 25942059,
ZHAI, C., D. SUMMER, C. RANGGER, G. FRANSSEN, P. LAVERMAN, H. HAAS, M. PETŘÍK, R. HAUBNER, C. DECRISTOFORO
Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates. Molecular Pharmaceutics. 2015, 12(6), 2142-2150, ISSN: 1543-8384, PMID: 25941834,
ŘEZNÍČKOVÁ, E., A. POPA, T. GUCKÝ, M. ZATLOUKAL, L. HAVLICEK, V. BAZGIER, K. BERKA, R. JORDA, I. POPA, A. NASEREDDIN, C. JAFFE, V. KRYŠTOF, M. STRNAD
2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro. Bioorganic and Medicinal Chemistry Letters. 2015, 25(11), 2298-2301, ISSN: 0960-894X, PMID: 25937014,
HEZOVA, R., A. KOVARIKOVA, J. SROVNAL, M. ZEMANOVÁ, T. HARUSTIAK, J. EHRMANN, M. HAJDÚCH, M. SVOBODA, M. SACHLOVA, O. SLABÝ
Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus. Diagnostic Pathology. 2015, 10(-), Article Number: 42, ISSN: 1746-1596, PMID: 25928282,
KAPLANEK, R., M. JAKUBEK, J. RAK, Z. KEJIK, M. HAVLIK, B. DOLENSKY, I. FRYDRYCH, M. HAJDÚCH, M. KOLÁŘ, K. BOGDANOVÁ, J. KRALOVA, P. DŽUBÁK, V. KRAL
Caffeine-hydrazones as anticancer agents with pronounced selectivity toward T-lymphoblastic leukaemia cells. Bioorganic Chemistry. 2015, 60(-), 19-29, ISSN: 0045-2068, PMID: 25912310,
DAS, V., F. BRUZZESE, P. KONEČNÝ, F. IANNELLI, A. BUDILLON, M. HAJDÚCH
Pathophysiologically relevant in vitro tumor models for drug screening. Drug Discovery Today. 2015, 20(7), 848-55, ISSN: 1359-6446, PMID: 25908576,
DAS, V., F. BRUZZESE, P. KONEČNÝ, F. IANNELLI, A. BUDILLON, M. HAJDÚCH
Pathophysiologically relevant in vitro tumor models for screening of anticancer compounds. Drug Discovery Today. 2015, 20(7), 848-55, ISSN: 1359-6446, PMID: 25908576.